Related Experiment Video
Updated: Apr 21, 2026
04:08
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
Published on: June 27, 2025
1.3K
Caesarean scar pregnancy: a 10-year experience
Jennifer K Y Ko1, Raymond H W Li, Vincent Y T Cheung
1Department of Obstetrics and Gynecology, Queen Mary Hospital, University of Hong Kong, Hong Kong SAR, China.
The Australian & New Zealand Journal of Obstetrics & Gynaecology
|October 29, 2014
Summary
This study reviewed caesarean scar pregnancies (CSP), finding intralesional methotrexate effective for stable patients. Ultrasound diagnosed all cases, with 80% success using this medical management approach.
Area of Science:
- Reproductive Medicine
- Gynecologic Surgery
Background:
- Caesarean scar pregnancy (CSP) is a rare but potentially life-threatening condition.
- Early diagnosis and appropriate management are crucial for patient outcomes.
Purpose of the Study:
- To review the management and outcomes of women diagnosed with caesarean scar pregnancy (CSP).
- To evaluate the effectiveness of intralesional methotrexate in treating CSP.
Main Methods:
- Retrospective review of 22 women diagnosed with CSP between 2004 and 2013.
- Diagnosis confirmed via ultrasound, with characteristic findings at the caesarean scar site.
- Treatment outcomes, including human chorionic gonadotropin normalization and sonographic resolution, were analyzed.
Main Results:
- Twenty-two cases of CSP were identified, with diagnosis at a median gestational age of 6.7 weeks.
- Ultrasound revealed a heterogeneous mass at the caesarean scar site in all cases.
- Intralesional methotrexate achieved an 80% success rate in managing CSP.
Conclusions:
- There is no single consensus on the optimal management strategy for CSP.
- Medical management with intralesional methotrexate is a viable and acceptable treatment option for clinically stable women with CSP.
